Ruxolitinib phosphate (INCB018424 phosphate) 是一种有效的 JAK1/2 抑制剂， IC50 分别为3.3 nM/2.8 nM，比JAK3选择性高130倍。

GLPG0634 (analog) 是一种 JAK 广谱性抑制剂，对 JAK1/JAK2/JAK3 的 IC50 值为 50-200 nM。

Napabucasin 是 STAT3 的抑制剂，抑制癌症干细胞活性。

Tofacitinib是 JAK3/2/1 抑制剂，IC50 分别为1，20 和 112 nM。

Piperlongumine 是从荜茇中得到的生物碱，具有抗炎、抗菌、抗血管生成、抗氧化、抗肿瘤和抗糖尿病等活性。在肿瘤细胞中，Piperlongumine 能够诱导 ROS 和凋亡。Piperlongumine 具有抗心肌纤维化的作用，通过抑制 ERK1/2 信号通路抑制肌成纤维细胞的转化。

BTZ043 是 DprE1 的抑制剂，它对结核分枝杆菌 H37Rv (M. tuberculosis H37Rv) 和耻垢分枝杆菌 (Mycobacterium smegmatis) 的 MIC 值分别为 2.3 nM 和 9.2 nM。

S-Ruxolitinib (INCB018424) in stock,price: 300 USD/100mg. S-Ruxolitinib is the chirality of INCB018424, which is the first potent, selective, JAK1/2 inhibitor to enter the clinic with IC50 of 3.3 nM/2.8 nM, >130-fold selectivity for JAK1/2 versus JAK3. Ph

A potent and highly selective JAK3 inhibitor with IC50 of 0.15 nM.

Baricitinib phosphate(INCB 028050; LY 3009104) is a selective JAK1 and JAK2 inhibitor with IC50 of 5.9 nM and 5.7 nM, ~70 and ~10-fold selective versus JAK3 and Tyk2, no inhibition to c-Met and Chk2,showed potent activity against COVID-19(SARS-COV-2).

Hispidulin is a natural flavone with a broad spectrum of biological activities. Hispidulin is a Pim-1 inhibitor with an IC50 of 2.71 μM.

BMS-911543 is a potent and selective inhibitor of JAK2 with IC50 of 1.1 nM, approximately 350-, 75- and 65-fold selective to JAK1, JAK3 and TYK2, respectively.

AZD1480 is a novel ATP-competitive JAK2 inhibitor with IC50 of 0.26 nM, selectivity against JAK3 and Tyk2, and to a smaller extent against JAK1. Phase 1/2.

NVP-BSK805 is a potent and selective ATP-competitive JAK2 inhibitor with IC50 of 0.5 nM; >20-fold selectivity towards JAK1, JAK3 and TYK2.

FLLL32, a novel curcumin analogue, is a potent STAT3 inhibitor.